Micronutrient Deficiencies Seen in More Than 45 Percent With Type 2 Diabetes
By Elana Gotkine HealthDay Reporter
THURSDAY, Jan. 30, 2025 -- More than 45 percent of patients with type 2 diabetes (T2D) have micronutrient deficiencies, with the most prevalent deficiency being vitamin D, according to a meta-analysis published online Jan. 28 in BMJ Nutrition Prevention & Health.
Daya Krishan Mangal, Ph.D., from the Indian Institute of Health Management Research in Jaipur, and colleagues conducted a comprehensive assessment of the burden of multiple micronutrient deficiencies among patients with T2D. A total of 132 studies with 52,501 participants were included in the analysis.
The researchers found that the pooled prevalence of multiple micronutrient deficiencies was 45.30 percent among patients with T2D. The pooled prevalence was higher in women with T2D (48.62 percent) than in men (42.53 percent). The most prevalent micronutrient deficiency was vitamin D followed by magnesium (60.45 and 41.95 percent, respectively). The metformin-consuming group had higher B12 deficiency (28.72 percent). Across World Health Organization regions, there was variation seen in the prevalence of micronutrient deficiency.
"Micronutrient deficiencies may influence glucose metabolism and insulin signaling pathways, leading to the onset and progression of T2D," the authors write.
One author disclosed ties to Abbott, which funded the study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted January 2025
Read this next
Race, Ethnicity Influence Sodium Sources, Sodium Reduction Behavior
WEDNESDAY, May 28, 2025 -- There are similarities and differences in the sources of sodium and sodium reduction behaviors between racial and ethnic groups, according to a study...
ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death
WEDNESDAY, May 28, 2025 -- For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for obesity-related...
Semaglutide Plus Intensive Behavioral Therapy Most Beneficial for Weight Loss
FRIDAY, May 23, 2025 -- Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.